213738-39-7

Basic information

• Product Name: 1-O-oleyl-rac-glycero-3-p-toluenesulfonate
• Synonyms: 1-O-oleyl-rac-glycero-3-p-toluenesulfonate
• CAS NO: 213738-39-7
• Molecular Weight: 496.752
• Mol File: 213738-39-7.mol
• Article Data: 2

Chemical Properties

• CAS DataBase Reference: 1-O-oleyl-rac-glycero-3-p-toluenesulfonate(CAS DataBase Reference)
• NIST Chemistry Reference: 1-O-oleyl-rac-glycero-3-p-toluenesulfonate(213738-39-7)
• EPA Substance Registry System: 1-O-oleyl-rac-glycero-3-p-toluenesulfonate(213738-39-7)

Safety Data

• Hazardous Substances Data: 213738-39-7(Hazardous Substances Data)

Upstream product

• 143-28-2 oleoyl alcohol 
• 118712-54-2 glycidyl p-toluenesulfonate 

Downstream Products

• 60501-41-9 oleyl-glycidyl ether 

Relevant articles and documents

COMPOSITIONS AND METHODS FOR TREATMENT OF CENTRAL NERVOUS SYSTEM TUMORS

Compounds, pharmaceutical compositions, and methods for treating cancer, in particular brain cancer, are provided, including amphiphilic fatty acid/alcohol ethers (AIPs) comprising endocannabinoid and FABP motifs covalently linked to a beta-adrenoreceptor antagonist motif in one molecule. The invention includes methods for inhibiting growth of brain cancer cells by contacting the compound(s) with brain cancer cells. The invention provides a method for treating both brain cancer and brain cancer metastases, and for suppression of regrowth of brain cancer cells after radiation, surgical treatment, or chemotherapy of brain cancer. The invention also comprises an optimized chemical synthesis of the AIP compounds and methods of using the compounds, alone or in combination with another agent, for suppressing the growth of brain cancer cells, and enhancing survival of normal CNS cells, or improving recuperation from radiation, surgical or chemotherapy.